瘤微环境中的代谢竞争是癌症进展的驱动力
Chih-Hao Chang1, Jing Qiu1, David O'Sullivan1
1Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Cell
|September 1, 2015
概括
瘤通过消耗葡萄糖来限制T细胞,从而损害它们的抗癌功能. 通过免疫疗法恢复T细胞的葡萄糖代谢可以增强它们的抗癌能力.
科学领域:
- 免疫学
- 癌症生物学
- 代谢途径
背景情况:
- 抗原识别,慢性激活或免疫抑制等因素往往阻碍了T细胞介导的癌症免疫力.
- 瘤微环境对免疫细胞功能构成独特的挑战.
研究的目的:
- 研究瘤葡萄糖消耗在限制T细胞抗癌活性中的作用.
- 探索代谢干预和免疫疗法如何影响瘤微环境中的T细胞功能.
主要方法:
- 使用小鼠肉瘤模型研究T细胞反应.
- 分析T细胞代谢活动,包括mTOR信号传递,糖解和干扰素- (IFN-γ) 生产.
- 研究了增强瘤糖解和使用检查点阻断抗体 (抗CTLA-4,抗PD-1,抗PD-L1) 的效果.
- 研究了PD- L1阻断对瘤糖解和T细胞功能的直接影响.
主要成果:
- 瘤的葡萄糖消耗会对T细胞进行代谢限制,降低它们的mTOR活性,糖解能力和IFN-γ的产生,从而促进瘤的生长.
- 在瘤中增强糖分分解可以克服T细胞介导的瘤控制.
- 临床检查点阻断抗体恢复瘤微环境的葡萄糖,使T细胞糖解和IFN-γ产生.
- 通过影响mTOR活性和关键的糖解酶,阻断瘤中的PD- L1抑制了它们的糖解.
结论:
- 瘤所造成的代谢限制是癌症中T细胞低反应的关键机制.
- 向瘤代谢和利用免疫疗法可以恢复T细胞功能以改善癌症免疫力.
相关概念视频
The Tumor Microenvironment
8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment
3.1K
3.1K
Adaptive Mechanisms in Cancer Cells
7.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Adaptive Mechanisms in Cancer Cells
4.3K
4.3K
Tumor Progression
7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
Tumor Progression
3.6K
3.6K


